These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12113905)

  • 1. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.
    Potschka H; Fedrowitz M; Löscher W
    Neurosci Lett; 2002 Jul; 327(3):173-6. PubMed ID: 12113905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
    Potschka H; Fedrowitz M; Löscher W
    Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain.
    Potschka H; Fedrowitz M; Löscher W
    Neuroreport; 2001 Nov; 12(16):3557-60. PubMed ID: 11733711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
    Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
    Römermann K; Helmer R; Löscher W
    Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats.
    Potschka H; Löscher W
    Epilepsia; 2001 Oct; 42(10):1231-40. PubMed ID: 11737157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of multidrug transporters by verapamil or probenecid does not alter blood-brain barrier penetration of levetiracetam in rats.
    Potschka H; Baltes S; Löscher W
    Epilepsy Res; 2004 Feb; 58(2-3):85-91. PubMed ID: 15120740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].
    Herranz JL; Arteaga R; Armijo JA
    Neurologia; 1994 Nov; 9(9):410-7. PubMed ID: 7811493
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.
    Seegers U; Potschka H; Löscher W
    Epilepsia; 2002 Jul; 43(7):675-84. PubMed ID: 12102668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new antiepileptic drugs lamotrigine and felbamate are effective in phenytoin-resistant kindled rats.
    Ebert U; Reissmüller E; Löscher W
    Neuropharmacology; 2000 Jul; 39(10):1893-903. PubMed ID: 10884570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.
    Potschka H; Löscher W
    Neuroreport; 2001 Aug; 12(11):2387-9. PubMed ID: 11496115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
    Ma A; Wang C; Chen Y; Yuan W
    Drug Des Devel Ther; 2013; 7():1447-54. PubMed ID: 24348021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABC Transporters and Drug Resistance in Patients with Epilepsy.
    Feldmann M; Koepp M
    Curr Pharm Des; 2016; 22(38):5793-5807. PubMed ID: 27514707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier penetration of felbamate.
    Cornford EM; Young D; Paxton JW; Sofia RD
    Epilepsia; 1992; 33(5):944-54. PubMed ID: 1396440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine pharmacokinetics in patients receiving felbamate.
    Gidal BE; Kanner A; Maly M; Rutecki P; Lensmeyer GL
    Epilepsy Res; 1997 Apr; 27(1):1-5. PubMed ID: 9169285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice.
    Cuadrado A; Bravo J; Armijo JA
    Eur J Pharmacol; 2003 Mar; 465(1-2):43-52. PubMed ID: 12650832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives.
    Langeh U; Chawla P; Gupta GD; Singh S
    CNS Neurol Disord Drug Targets; 2020; 19(10):741-749. PubMed ID: 32814543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential pharmacokinetic interaction between felbamate and phenobarbital.
    Gidal BE; Zupanc ML
    Ann Pharmacother; 1994 Apr; 28(4):455-8. PubMed ID: 8038465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.